Method for rapidly and accurately detecting novel duck positive reovirus based on RAA-CRISPR-Cas13a and application

Through the detection method based on the RAA-CRISPR-Cas13a system, specific RAA primers and crRNA are used to combine RNA reporter probes to solve the problem of false positive and high equipment requirements for the new duck reovirus detection in the prior art. It realizes fast, sensitive and reliable on-site inspection, suitable for applications in areas with limited resources.

CN119061202APending Publication Date: 2024-12-03SOUTHWEST UNIV

Patent Information

Application Number
CN202411413225.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2024-10-10
Filing Date
2024-10-11
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The prior art is difficult to detect new types of reovirus quickly, sensitively and reliably in areas with limited resources, and there are false positive problems and high equipment requirements.

Method used

Using the detection method based on the RAA-CRISPR-Cas13a system, by designing specific RAA primers and crRNA, combining RNA reporter probes, on-site detection without professional equipment is achieved, and results are interpreted using test strips.

Benefits of technology

It realizes rapid detection within 40 minutes at room temperature, with a sensitivity of 100copies/μL, avoids false positives, is easy to operate, and has reliable results, which is suitable for applications in basic veterinary and farms.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119061202A_ABST
    Figure CN119061202A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biochemistry and molecular biology, and particularly discloses a method for detecting novel duck positive reovirus (NDRV) nucleic acid through RAA-CRISPR-Cas13a and application of the method. According to the invention, NDRV nucleic acid detection based on an RAA-CRISPR-Cas13a enzyme molecular system is established based on the designed RAA primer pair and crRNA, the system has strong specificity and high sensitivity, rapid detection of NDRV can be realized within 40 minutes, and the detection sensitivity reaches 100 copies / [mu] L. In addition, according to the system, expensive test equipment does not need to be operated in a standard professional laboratory, and field detection of clinical samples can be achieved through the portable visual transverse flow test strip.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of biochemistry and molecular biology, and relates to a novel duck orthoreovirus detection method and application based on a RAA-CRISPR-Cas13a enzyme molecular system. Background Art

[0002] The novel duck orthoreovirus (NDRV) has been prevalent in my country in recent years. It is an immunosuppressive disease characterized by splenomegaly, hemorrhage, and necrosis, which has brought serious harm to the waterfowl farming industry. The NDRV genome is over 23kb in length and contains 10 gene segments. Genetic variation of the viral genome often occurs due to accumulation of point mutations and gene recombination. How to select suitable regions from the huge NDRV genome sequence as detection targets is critical for specific and efficient detection of NDRV.

[0003] The S1 gene of NDRV is a polycistronic structure, containing three open reading frames, encoding p10, p17 and σC proteins, of which σC is an important structural protein of NDRV. During the infection of NDRV virus, σC protein monomers are activated to form homotrimers to play a role and can induce the host to produce specific neutralizing antibodies. It is an important virulence factor and protective antigen. At the same time, under the continuous immune selection pressure, the σC protein encoding gene is the gene segment most prone to gene mutation, and it is also an important gene segment that distinguishes NDRV from the previous epidemic strains. Therefore, research on σC protein is the key point of NDRV virus-specific detection.

[0004] At present, the main diagnostic methods for NDRV in clinical practice are serological diagnosis and molecular biological diagnosis. Among them, ELISA technology is prone to false positives, and qPCR technology requires professional fluorescence detection equipment, which cannot meet the detection needs of resource-limited areas. There is a lack of detection methods that have the advantages of simple operation, high sensitivity, low cost of reagents and consumables, good specificity, and low requirements for instruments and equipment. It is urgent to establish a rapid, sensitive and reliable detection technology. Summary of the invention

[0005] In view of the above-mentioned prior art, the purpose of the present invention is to provide a method and application for rapid and accurate detection of a new duck orthoreovirus based on RAA-CRISPR-Cas13a. The detection method established by the present invention can be detected on-site (also known as on-site detection), does not require professional equipment and personnel, is easy to operate, and has fast and reliable results. Diagnosis can be made by observing the fluorescence state and the results of the test strip, providing a powerful molecular tool for preventing and controlling the spread of NDRV.

[0006] To achieve the above object, the present invention adopts the following technical solution:

[0007] In a first aspect, the present invention provides a novel duck orthoreovirus detection composition, the detection composition comprising: a specific RAA primer pair, crRNA for detecting the novel duck orthoreovirus, an RNA reporter probe and Cas13a;

[0008] The nucleotide sequences of the RAA primer pair are shown in SEQ ID NO.1-SEQ ID NO.2;

[0009] The crRNA nucleotide sequence for detecting the novel duck orthoreovirus is shown in SEQ ID NO.3;

[0010] The RNA reporter probe is an RNA reporter probe for fluorescence detection or an RNA reporter probe for test strip detection.

[0011] The RNA probe for fluorescence detection is an RNA probe double-labeled with a fluorescent group and a fluorescence quenching group, and its sequence is FAM-rUrUrUrUrUrU-BHQ1; the RNA reporter probe for test strip detection is an RNA probe double-labeled with fluorescein isothiocyanate and biotin, and its sequence is FITC-rUrUrUrUrUrU-Bio.

[0012] The second aspect of the present invention provides the use of the above-mentioned detection composition in the preparation of a visual detection product for detecting a novel duck orthoreovirus.

[0013] In a third aspect, the present invention provides a novel RAA-CRISPR-Cas13a detection kit for duck orthoreovirus, wherein the RAA-CRISPR-Cas13a detection kit contains the above-mentioned detection composition.

[0014] The RAA-CRISPR-Cas13a detection kit also includes a novel duck orthoreovirus positive plasmid standard, and the novel duck orthoreovirus positive plasmid standard is prepared by the following method:

[0015] The novel duck orthoreovirus σC gene was amplified to obtain an amplified product, which was then connected to the PMD-19T vector. Positive clones were screened and plasmid DNA was extracted to prepare a novel duck orthoreovirus positive plasmid standard.

[0016] In a fourth aspect, the present invention provides the use of the above-mentioned RAA-CRISPR-Cas13a detection kit in conducting an epidemiological survey of a novel duck orthoreovirus.

[0017] In a fifth aspect, the present invention provides a novel duck orthoreovirus kit detection method based on the RAA-CRISPR-Cas13a system, comprising the following steps:

[0018] (1) Extract RNA from the sample to be tested and reverse transcribe it into cDNA;

[0019] (2) Using the cDNA obtained in step (1) as a template, use the RAA-CRISPR-Cas13a detection kit to perform real-time PCR amplification on the sample to be tested, and observe the amplification curve.

[0020] In a sixth aspect, the present invention provides a novel duck orthoreovirus test strip detection method based on the RAA-CRISPR-Cas13a system, comprising the following steps:

[0021] (1) Extract RNA from the sample to be tested and reverse transcribe it into cDNA;

[0022] (2) Using the cDNA obtained in (1) as a template, a reaction is carried out based on the RAA-CRISPR-Cas13a system detection reaction system, the reaction product is diluted 2-20 times, the binding pad end of the test strip is inserted into the reaction diluent, and after the reading area is soaked, it is taken out and laid flat, and the result is read within 10 minutes.

[0023] The result interpretation standard is: if a red stripe appears at the T line position of the test strip or a red stripe appears at both the T line and the C line position, it indicates that the sample to be tested is positive; if a red stripe does not appear at the T line position of the test strip, but a red stripe appears at the C line, it indicates that the sample to be tested is negative; if a red stripe does not appear at both the T line position and the C line position of the test strip, it indicates that the test strip or amplification reagent used has been damaged, expired, or there is an error in the operation during the test process.

[0024] The present invention has the following beneficial effects

[0025] 1. The present invention uses the NDRVσC gene as the detection target, designs RAA primer pairs and crRNA, and establishes a novel duck orthoreovirus detection method based on the RAA-CRISPR-Cas13a system. Based on the strong specificity of the detection system for NDRV, it can avoid the problem of false positives and can achieve rapid detection of NDRV within 40 minutes at room temperature, with a detection sensitivity of 10 0 copies / μL.

[0026] 2. The NDRV nucleic acid detection method based on the RAA-CRISPR-Cas13a enzyme molecular system established in the present invention does not require the operation of expensive test equipment in a standard professional laboratory. On-site detection of clinical samples can be achieved through a portable visual lateral flow test strip. The operation is simple and the results are fast and reliable. It provides a new practical technology for the epidemiological investigation and diagnosis of NDRV, especially for veterinary grassroots and farms, which is conducive to the effective prevention and control of NDRV. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 Schematic diagram of detection based on the RAA-CRISPR-Cas13a system.

[0028] Figure 2 Schematic diagram of sequence design of RAA primers and crRNA.

[0029] Figure 3 This is a graph showing the specific results of fluorescence detection based on the RAA-CRISPR-Cas13a system.

[0030] Figure 4 This is a sensitivity result diagram based on fluorescence detection of the RAA-CRISPR-Cas13a system; Figure 4 A in the middle is the fluorescence detection of the RAA-CRISPR-Cas13a system of NDRV at different concentrations; Figure 4 B in the figure is the calculation formula for the copy number of the NDRV standard positive plasmid.

[0031] Figure 5 This is a graph showing the repeatability results of fluorescence detection based on the RAA-CRISPR-Cas13a system.

[0032] Figure 6 Schematic diagram of the portable test strip lateral flow detection based on RAA-CRISPR-Cas13a.

[0033] Figure 7 This is a graph showing the specificity results of the RAA-CRISPR-Cas13a portable test strip detection.

[0034] Figure 8 This is a sensitivity result diagram based on RAA-CRISPR-Cas13a portable test strip detection; Figure 8 A in the middle is a schematic diagram of a portable test strip test. Figure 8 Figure B is a bar graph showing the relative strength of the NDRV portable test strip.

[0035] Fig. 9 This is a result diagram of the application of the RAA-CRISPR-Cas13a system to detect clinical samples; Fig. 9 A in the middle is the result graph of three detection methods detecting known samples; Fig. 9 Figure B shows the results of detecting unknown samples using three detection methods. DETAILED DESCRIPTION

[0036] It should be noted that the following detailed descriptions are illustrative and are intended to provide further explanation of the present application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present application belongs.

[0037] The following detailed description is for illustrative purposes only and is intended to provide further explanation of the present application, rather than to limit the scope of the present invention.

[0038] As mentioned above, NDRV (novel duck reovirus, also known as duck reovirus type II) is a virus strain that is widely prevalent in the waterfowl farming industry and is seriously harmful. According to the results of the nucleic acid segmentation study of NDRV by Chen Shilong et al., NDRV has the characteristics of avian reovirus (ARV) in SDS-PAG. NDRV, avian reovirus (ARV) and Muscovy duck reovirus (MDRV) all belong to the Reoviridae family and the Orthoreovirus genus. Different reovirus strains prevalent in different regions of my country have the characteristics of host differences, regional differences and diverse pathogenicity. Studies have also shown that the genomes of these different reovirus strains are diverse, and their tissue tropism and antigenic structure are also different.

[0039] In the prior art, there are few reports on the combination of isothermal nucleic acid amplification and CRISPR / Cas13a for the detection of NDRV. "A rapid simultaneous detection of duck hepatitis A virus 3and novel duck reovirus based on RPA CRISPR Cas12a / Cas13a" discloses a detection method for simultaneously detecting DHAV-3 and NDRV infections based on the RPA-CRISPR Cas12a / Cas13a system. The journal uses specific primers designed for the S3 gene for the detection of NDRV. Since the S3 gene is a relatively conservative gene segment of reovirus, the variability of the S3 gene in different reovirus strains is not strong, and there is little difference between the reovirus strains. When the primers designed for the S3 gene are used to detect clinical samples, there is a problem of false positive detection of duck reovirus strains, and the detection specificity for NDRV is not strong.

[0040] In the full-length segment of the NDRV strain, the σC protein encoding gene in the S1 gene is the most variable gene segment in the genome. In the information library of different reovirus strains, it has the lowest homology and the greatest difference. It is the main gene used to distinguish NDRV from different types of reovirus strains in genetic evolution analysis. During the NDRV virus infection process, the σC protein monomer is activated to form a homotrimer to play a role and can induce the host to produce specific neutralizing antibodies. It is an important virulence factor and protective antigen. Therefore, research on the σC protein is the key point of NDRV virus-specific detection.

[0041] Although the σC protein coding gene is more targeted and specific for the detection of NDRV, in the process of primer design, due to the large base variation site of the σC protein coding gene, the comparison of the σC protein coding sequence of the currently popular NDRV strains is to obtain the conservative sequence for primer design, which is the biggest difficulty in primer design. In this regard, the present invention designs and screens primers for the conservative region of the σC protein coding gene of the popular NDRV strain, designs 5 RAA-F primers and 3 RAA-R primers, and uses primer pairs to screen one by one, and finally obtains the best primer sequence shown in SEQ ID NO.1-SEQ ID NO.2 of the present invention.

[0042] The RAA-CRISPR system is an emerging technology for rapid nucleic acid detection. Currently, there are no reports on the detection of NDRV based on the RAA-CRISPR-Cas13a system. The present invention uses the conserved nucleotide region of the σC gene as a detection target and establishes a novel duck orthoreovirus detection method based on the RAA-CRISPR-Cas13a system. The detection system has strong specificity for NDRV detection and can avoid false positive problems.

[0043] For a better understanding of the present invention, the present invention is further described below in conjunction with specific examples. Unless otherwise specified, the reagents and consumables used in the present invention are all commercially available. The experimental techniques and methods in the embodiments are all conventional methods and methods recommended by the reagent instructions.

[0044] The NDRV isolate used in the example is named duck / N-DRV-SDYC / China / 2018, and its GenBank accession number is ON009427-ON009436.

[0045] DHAV isolate name: Du / CH / JS2013, complete genome, GenBank accession number: KP721458.1.

[0046] The name of TMUV isolate is SDDZ, and its GenBank accession number is MH764606.

[0047] The name of the NGPV isolate, NMG21, comes from the master's thesis "Study on the Attenuation of the Novel Goose Parvovirus NMG21 Strain by Duck Embryo Passage", Shandong Agricultural University, Lv Hongmeng.

[0048] Example 1: RAA amplification primer design

[0049] The NDRVσC gene sequence (ON009436.1) was downloaded from NCBI, and its conserved nucleotide region was selected as the attachment site of the RAA primer. When designing primers, the primer length was controlled within 30-50 bases, the GC content was controlled between 40-60%, and the size of the amplified target fragment was controlled between 100-200bp, because too long or too short primers would affect the amplification efficiency. At the same time, special sequences such as forward / reverse repeat sequences and palindromic sequences were avoided in the primers to avoid the formation of secondary structures or hairpin structures.

[0050] According to the above RAA amplification primer design principles, specific RAA primer sequences were designed. After confirming their specificity at NCBI, the designed primers needed to have sufficient specificity. A large number of optimizations and tests were performed during the primer design process. A total of 5 RAA-F primers and 3 RAA-R primers were designed. The primer pairs were screened one by one, and the best primer sequence of the present invention was finally obtained. T7 RNA polymerase promoter (5'-TAATACGACTCACTATAGGG-3') was added to the 5' end of the forward primer. The RAA amplification primer sequences are shown in SEQ ID NO.1-SEQ ID NO.2

[0051] SEQ ID NO.1 (forward primer RAA-2-F):

[0052] TAATACGACTCACTATAGGG GCCGAGAGGAAGCTTGAGAAAGAAGTGAAAGG;

[0053] SEQ ID NO.2 (reverse primer RAA-2-R):

[0054] TTATGCTTCCGGTCGAGTGTGTCTGTTGAATTC.

[0055] Example 2: crRNA design

[0056] Cas13a is an RNA-mediated endonuclease. When the target RNA has a protospacer flanking sequence (PFS), after the Cas13a-crRNA complex recognizes the PFS, the crRNA guide sequence undergoes base-complementary pairing with the target RNA, inducing a synergistic conformational change in Cas13a, activating the RNase activity of Cas13a, and specifically cis-cutting the target RNA, followed by trans-cutting the nearby RNA in a non-specific manner.

[0057] The PFS sequence of Cas13a is located at the 3' end of the spacer region and is composed of A, U or C bases. Therefore, crRNA is designed according to PFS, that is, the highly conserved target region of the NDRVσC gene is found and the 3' end is A, U or C, and 28nt (CGGCGCTTTGGAGGGATTTGATCTGTGT) is selected forward. Finally, the selected sequence is added to the hairpin structure sequence fixed by Cas13a (GATTTAGACTACCCCAAAAACGAAGGGGACTAAAAC) to obtain the crRNA sequence shown in SEQ ID NO.3.

[0058] Table 1: crRNA nucleic acid sequences

[0059]

[0060] Example 3: Construction of a novel duck orthoreovirus positive plasmid standard

[0061] Design the PCR primer pair for amplifying the NDRVσC gene shown in SEQ ID NO.4-SEQ ID NO.5, PCR

[0062] The amplified product was purified by gel extraction kit (Sangon Biotec, cat. no. B518131) and ligated to pMD-19T

[0063] The vector was cloned and transformed into competent cells DH5α, positive clones were screened by sequencing, and plasmids were extracted using a kit (SangonBiotec, cat. no. B518191) to obtain a new duck orthoreovirus positive plasmid standard.

[0064] SEQ ID NO.4(NDRV-F): ATGGATCGCAACGAGGTG;

[0065] SEQ ID NO. 5 (NDRV-R): GCCCRTGGCGACGGTGAA.

[0066] Example 4: RAA amplification

[0067] The RAA nucleic acid amplification kit (Qitian, cat. no. B00000) of Jiangsu Qitian Gene Biotechnology Co., Ltd. was used, and the standard positive plasmid pMD-19T-NDRVσC was used as a template. The RAA primers with T7 promoter shown in SEQ ID NO.1-SEQ ID NO.2 were used for amplification. The reaction reagents other than the template DNA and magnesium acetate were premixed and transferred to the reaction tube containing the lyophilized powder preparation. The lyophilized powder was gently re-dissolved evenly by hand, and the liquid was collected to the bottom of the tube by brief centrifugation. Open the reaction unit, add 5 μL of magnesium acetate to the reaction tube cap, and then add 1 μL of template DNA to each reaction unit, mix by hand and collect by centrifugation, and react for 40 minutes at 37°C. The specific reaction system is as follows:

[0068] Table 2: RAA amplification system

[0069]

[0070]

[0071] After the reaction, 50 μL of phenol / chloroform (1:1) was added to the tube, and the mixture was shaken and centrifuged until layers were separated. 2% agarose gel was prepared, and 10 μL of the supernatant was taken for electrophoresis detection, and the amplified product was recovered from the gel (Sangon Biotec, cat. no. B518131).

[0072] Example 5: Nucleic acid detection system based on RRA-CRISPR-Cas13a

[0073] The RAA amplification product obtained in Example 4 was used as a template, and the CRISPR / Cas13a enzyme digestion system was added to configure the RAA-CRISPR-Cas13a detection system described in Table 3. After the system was configured on ice, it was mixed and centrifuged and placed on a fluorescent quantitative PCR instrument. The FAM lane was selected and reacted at 37° C. for 50 minutes. The fluorescent signal was collected every 1 minute. After the reaction was completed, the data was saved for analysis, and then the reaction tube was placed on a blue light gel imager to observe the fluorescent state and take pictures for record.

[0074] Table 3: RAA-CRISPR-Cas13a detection system

[0075]

[0076] Example 6: Methodological detection of fluorescence detection of RAA-CRISPR-Cas13a system

[0077] (1) Specificity test of the fluorescence detection method of the RAA-CRISPR-Cas13a system:

[0078] Duck hepatitis A virus (DHAV), Tembusu virus (TMUV), and new duck-origin goose parvovirus (NGPV) were selected, viral RNA was extracted using trizol, and RNA was reverse transcribed into cDNA using a reverse transcription kit (KANGWEI, cat. no. CW2569M). After RAA isothermal amplification, the complete system shown in Table 4 was configured on ice using ssRNA fluorescent reporter molecules, and placed in a BIOER fluorescent PCR instrument, incubated at 37°C for 50 minutes, and the fluorescent signal was recorded every 1 minute. After the reaction was completed, the numerical results were saved and the fluorescence state was observed.

[0079] Table 4: RAA-CRISPR-Cas13a detection system based on fluorescence detection

[0080]

[0081] The results are as follows Figure 3 As shown, the fluorescence value of the NDRV sample increased rapidly after the reaction started, while DVHV, TMUV, and DPV showed no fluorescence. The above results show that the RAA-CRISPR-Cas13a fluorescence detection method established in the present invention has good specificity.

[0082] (2) Sensitivity test of the fluorescence detection method of the RAA-CRISPR-Cas13a system:

[0083] The concentration of the standard positive plasmid pMD-19T-NDRVσC was measured, and its copy number was calculated according to the formula. After ten-fold gradient dilution (10 7 copies / μL-10 0 The amplified product was used as a template, and the complete system shown in Table 4 was prepared on ice using ssRNA fluorescent reporter molecules. The system was placed in a BIOER fluorescent quantitative PCR instrument and incubated at 37°C for 50 minutes, with the fluorescent signal recorded every 1 minute.

[0084] The results are as follows Figure 4 As shown in Figure 2, the minimum detection limit of the RAA-CRISPR-Cas13a fluorescence detection method established by the present invention is 10 0 copies / μL, and with the increase of dilution, the fluorescence intensity gradually weakened. When the reaction time was 30 minutes, the initial rate of fluorescence enhancement was linearly related to the NDRV template concentration, which was consistent with the kinetics of the enzyme reaction.

[0085] (3) Repeatability test of fluorescence detection method of RAA-CRISPR-Cas13a system

[0086] Use 10 7 copies / μL-10 0The purified RAA product with a dilution of 10 copies / μL was used as a template. The experiment was repeated within the batch for 3 times, and the experiment was repeated between batches at different times. A negative control was set up (the template for RAA amplification was sterile deionized water). The configured system was placed in a BIOER fluorescent PCR instrument and incubated at 37°C for 50 minutes, and the fluorescent signal was recorded every 1 minute.

[0087] The results are as follows Figure 5 As shown, the RAA-CRISPR-Cas13a fluorescence detection method established in the present invention has good repeatability.

[0088] Example 7: Construction of portable test strips based on the RAA-CRISPR-Cas13a system

[0089] (1) Principle of construction of NDRV portable test strip based on RAA-CRISPR-Cas13a system

[0090] like Figure 6 As shown, on the lateral flow test strip, a biotin-ligand line will bind to biotin and capture all intact RNA probes. If the sample to be tested is a negative sample, the FITC-RNA-biotin reporter gene will first be fully coupled to the anti-FITC antibody, and then the coupling product will be intercepted by the biotin ligand at the quality control line (C line). If it is a positive sample, Cas13a will exert its accessory cleavage activity after activation, and the FITC-RNA-biotin reporter gene will then be cleaved. The anti-FITC antibody labeled with gold nanoparticles (NPs) will flow to the top band indicating the presence of the target, and the conjugate of the anti-FITC antibody and FITC will accumulate more at the detection line (T line), while the accumulation at the C line will decrease.

[0091] (2) Construction method of NDRV portable test strip based on RAA-CRISPR-Cas13a system

[0092] The test paper consists of a sample pad, a conjugate pad, a detection line, an accusation line, and an absorption pad. According to the siphon effect of the test paper, the liquid dripped on the test paper passes through the conjugate pad, the detection line, and the control line in sequence. First, add the chloroauric acid solution to the gold nitrate solution, stir evenly, then add the sodium hydroxide solution, stir until the solution turns red, complete the preparation of the colloidal gold solution, and purify it. Select an antibody that specifically binds to the target to be tested, mix the antibody solution with the colloidal gold solution, and fix the antibody on the colloidal gold surface. Stick the NC membrane on the bottom plate and draw a line, spray gold and dry it, then assemble the absorbent paper and the gold label pad, and finally complete the construction of the NDRV portable test strip.

[0093] (3) NDRV portable test strip detection based on RAA-CRISPR-Cas13a system

[0094] Extract RNA from the sample to be tested and reverse transcribe it into cDNA; use cDNA as a template to perform RAA amplification to obtain RAA amplification products. Further, use the RAA amplification products as templates to configure the RAA-CRISPR-Cas13a system test strip detection reaction system shown in Table 5, place the reaction system in a metal bath, incubate at 37°C for 40 minutes to obtain a reaction product, dilute the reaction product 20 times, insert the test strip binding pad end into the reaction diluent, take out and lay flat after the interpretation area is soaked, and interpret the result within 10 minutes.

[0095] Table 5: RAA-CRISPR-Cas13a detection system based on test strip detection

[0096]

[0097]

[0098] If a red stripe appears at the T line position of the sample to be tested, or a red stripe appears at both the T line and the C line position, it means that the sample to be tested is positive;

[0099] If no red band appears at the T line of the sample to be tested, but a red band appears at the C line, it means that the sample to be tested is negative;

[0100] If no red strips appear at the T-line and C-line positions of the sample to be tested, it indicates that the test strip or amplification reagent used may be damaged, ineffective, or there may be an error in the operation during the test.

[0101] Example 8: Methodological testing of portable test strips for RAA-CRISPR-Cas13a system

[0102] (1) Specificity test of the portable test strip detection method of the RAA-CRISPR-Cas13a system

[0103] The cDNAs of NDRV, TMUV, DPV and DVHV were used as templates respectively, and the detection was carried out according to the test strip detection method shown in Example 7, and the results were read in time after the reaction was completed.

[0104] The results are as follows Figure 7 As shown, the T line of the test strip for detecting only NDRV showed a positive result, and the test strips of other virus samples were all negative. The above results show that the method for detecting NDRV established by the present invention has strong specificity and has no cross reaction with other viruses.

[0105] (2) Sensitivity test of the portable test strip detection method of the RPA-CRISPR-Cas13a system

[0106] The pMD-19T-NDRVσC standard plasmid was diluted in 10-fold series (107 copies / μL-10 0 copies / μL) as a template, and perform detection according to the test strip detection method shown in Example 7, and read the result in time after the reaction is completed.

[0107] The results are as follows Figure 8 As shown, the minimum detection limit of the NDRV detection method established by the present invention is 10 0 copies / μL.

[0108] Example 9: Clinical application detection of NDRV based on the RAA-CRISPR-Cas13a system

[0109] At the same time, the RAA-CRISPR-Cas13a method, PCR and fluorescence quantitative PCR provided by the present invention were used to detect 12 confirmed duck serum samples (9 NDRV positive and 3 NDRV negative), and the detection results of the three methods were consistent ( Fig. 9 A), showing 100% consistency. Subsequently, 16 duck sera suspected of NDRV infection were tested using three detection methods. Ten samples were positive for all three detection methods. Among the other six samples, two were positive for RAA-CRISPR-Cas13a and qPCR, indicating that in clinical applications, the results of RAA-CRISPR-Cas13a and qPCR were highly consistent and more sensitive than PCR ( Fig. 9 B), has good application prospects and clinical value.

[0110] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. A novel detection composition for duck orthoreovirus, characterized in that: The detection composition comprises: a specific RAA primer pair, crRNA for detecting a novel duck orthoreovirus, an RNA reporter probe and Cas13a; The nucleotide sequences of the RAA primer pair are shown in SEQ ID NO.1-SEQ ID NO.2; The crRNA nucleotide sequence for detecting the novel duck orthoreovirus is shown in SEQ ID NO.3; The RNA reporter probe is an RNA reporter probe for fluorescence detection or an RNA reporter probe for test strip detection.

2. The novel duck orthoreovirus detection composition according to claim 1, characterized in that: The RNA reporter probe used for fluorescence detection is FAM-rUrUrUrUrUrU-BHQ1; the RNA reporter probe used for test strip detection is FITC-rUrUrUrUrUrU-Bio.

3. Use of the detection composition according to claim 1 in preparing a visual detection product for detecting a novel duck orthoreovirus.

4. A novel RAA-CRISPR-Cas13a detection kit for duck orthoreovirus, characterized in that: The RAA-CRISPR-Cas13a detection kit contains the detection composition of claim 1.

5. The RAA-CRISPR-Cas13a detection kit according to claim 4, characterized in that The RAA-CRISPR-Cas13a detection kit also includes a novel duck orthoreovirus positive plasmid standard, and the novel duck orthoreovirus positive plasmid standard is prepared by the following method: The novel duck orthoreovirus σC gene was amplified to obtain an amplified product, which was then connected to the PMD-19T vector. Positive clones were screened and plasmid DNA was extracted to prepare a novel duck orthoreovirus positive plasmid standard.

6. Use of the RAA-CRISPR-Cas13a detection kit described in claim 4 or 5 in an epidemiological survey of a novel duck orthoreovirus.

7. A novel duck orthoreovirus kit detection method based on the RAA-CRISPR-Cas13a system, characterized in that: The steps include: (1) Extract RNA from the sample to be tested and reverse transcribe it into cDNA; (2) Using the cDNA obtained in step (1) as a template, the RAA-CRISPR-Cas13a detection kit according to claim 5 is used to perform real-time PCR amplification on the sample to be tested, and the amplification curve is observed.

8. A novel duck orthoreovirus test strip detection method based on the RAA-CRISPR-Cas13a system, characterized in that: The steps include: (1) Extract RNA from the sample to be tested and reverse transcribe it into cDNA; (2) Using the cDNA obtained in step (1) as a template, the reaction is carried out based on the RAA-CRISPR-Cas13a system detection reaction system, the reaction product is diluted 2-20 times, the binding pad end of the test strip is inserted into the reaction diluent, and after the interpretation area is soaked, it is taken out and laid flat, and the result is interpreted within 10 minutes.

9. The novel duck orthoreovirus test strip detection method according to claim 8, characterized in that: The result interpretation standard is: if a red strip appears at the T line position of the test strip or a red strip appears at both the T line and the C line position, it indicates that the sample to be tested is positive; if no red strip appears at the T line position of the test strip, but a red strip appears on the C line, it indicates that the sample to be tested is negative; if no red strip appears at both the T line position and the C line position of the test strip, it indicates that the test strip or amplification reagent used is damaged, invalid, or there is an error in the operation during the detection process.

Citation Information

Patent Citations

  • Detection system for detecting goose astrovirus type 2 based on RPA-CRISPR-Cas13a

    CN117568528A

  • RPA-CRISPR / Cas12a kit for detecting type II grass carp reovirus and application of RPA-CRISPR / Cas12a kit

    CN118600111A

Cited By

  • Reagent, kit and method for synchronously detecting waterfowl reoviruses MDRV and NDRV and application

    CN122357807A